An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region

Blood

Volumn 92, Issue 10, 1998, Pages 3793-3803

  Strissel, Pamela L ^a,b   Strick, Reiner ^a   Rowley, Janet D ^a   Zeleznik Le, Nancy J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b MC2115 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; DNA; DNA TOPOISOMERASE (ATP HYDROLYSING);

ARTICLE; CHROMOSOME 11Q; DNA STRAND BREAKAGE; EXON; GENE; HUMAN; HUMAN CELL; LYMPHATIC LEUKEMIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOUTHERN BLOTTING;

EID: 0032533231     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.10.3793.422a24_3793_3803     Document Type: Article

References (75)

1. Ziemin-Van Der Poel S, McCabe NR, Gill HJ, Espinosa R III, Patel Y, Harden A, Rubinelli P, Smith SD, LeBeau MM, Rowley JD, Diaz MO: Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 88:10735, 1991
2. Gu Y, Cimino G, Alder H, Nakamura T, Prasad R, Canaani O, Moir DT, Jones C, Nowell PC, Croce CM, Canaani E: The (4;11)(q21; q23) chromosome translocations in acute leukemias involve the VDJ recombinase. Proc Natl Acad Sci USA 89:10464, 1992
3. Djabali M, Selleri L, Parry P, Bower M, Young BD, Evans GA: A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias. Nat Genet 2:113, 1992
4. Tkachuk DC, Kohler S, Cleary ML: Involvement of ahomolog of Drosophila trithorax by 11q23 chromosomal translocation in acute leukemias. Cell 71:691, 1992
5. Rowley JD: Rearrangements involving chromosome band 11q23 in acute leukemia, in Rabbitts TH (ed): Seminars in Cancer Biology. London, UK, Academic, 1993, p 377
6. Bernard O, Berger R: Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations. Genes Chromosomes Cancer 13:75, 1995
7. Hillion J, Le Coniat M, Jonveaux P, Berger R, Bernard OA: AF6q21, a novel partner of the MLL gene in t(6;11)(q21;q23), defines a forkhead transcriptional factor subfamily. Blood 90:3714, 1997
8. So CW, Caldas C, Liu MM, Chen SJ, Huang QH, Gu LJ, Sham MH, Wiedemann LM, Chan LC: EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukamia. Proc Natl Acad Sci USA 94:2563, 1997
9. Sobulo OM, Borrow J, Tomek R, Reshmi S, Harrden A, Schlegelberger B, Housman D, Doggett NA, Rowley JD, Zeleznik-Le NJ: MLL is fused to a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3). Proc Natl Acad Sci USA 94:8732, 1997
10. Ida K, Kitabayashi I, Taki T, Taniwaki M, Noro K, Yamamoto M, Ohki M, Hayashi Y: Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13). Blood 90:4699, 1997
11. Mitelman F: Catalog of Chromosome Aberrations in Cancer (ed 5). New York, NY, Wiley-Liss, 1994
12. Thirman MJ, Gill HJ, Burnett RC, Mbangkollo D, Mccabe NR, Kobayashi H, Ziemin-Van Der Poel S, Kaneko Y, Morgan R, Sandberg AA, Chaganti RSK, Larson RA, LeBeau MM, Diaz MO, Rowley JD: Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 329:909, 1993
13. Kaneko Y, Shikano T, Maseki N: Clinical characteristics of infant acute leukemia with or without 11q23 translocations. Leukemia 2:672, 1988
14. Raimondi SC: Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood 81:2237, 1993
15. Sorensen PHB, Chen CS, Smith FO, Arthur DC, Bernstein DC, Domer PH, Korsmeyer SJ, Hammond GD, Kersey JH: Molecular rearrangements of chromosome band 11q23 are common in infant AML and are strongly correlated with monocytic or myelomonocytic phenotypes. J Clin Invest 93:429, 1994
16. Martinez-Climente, JA, Thirman MJ, Espinosa R III, Le Beau MM, Rowley JD: Detection of 11q23/MLL rearrangements in infant leukemias with fluorescent in situ hybridization and molecular analysis. Leukemia 9:1299, 1995
17. Gill Super HJ, McCabe NR, Thirman M, Larson RA, Le Beau MM, Pedersen-Bjergaard J, Preben P, Diaz M, Rowley JD: Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood 82:3705, 1993
18. Hunger SP, Tkachuk DC, Amylon MD, Link MP, Carroll AJ, Welborn JL, Willman CL, Cleary ML: HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities. Blood 81:3197, 1993
19. Pedersen-Bjergaard J, Rowley JD: The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 83:2780, 1994
20. Piu C-H, Riberio RC, Hancock ML, Rivera GK, Evans WE, Raimondi SC, Head DR, Behm FG, Mahmoud MH, Sandlund JT, Crist WM: Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N Engl J Med 325:1682, 1991
21. Domer PH, Head DR, Renganathan N, Raimondi SC, Yang E, Atlas M: Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11). Leukemia 9:1305, 1995
22. Gill Super H, Strissel P, Sobulo OM, Burian D, Reshmi S, Roe B, Zeleznik-Le NJ, Diaz MO, Rowley JD: Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia. Genes Chromosom Cancer 20:185, 1997
23. Rasio D, Schichman SA, Negrini M, Cannaani E, Croce CM: Complete exon structure of the ALL1 gene. Cancer Res 56:1766, 1996
24. Gu Y, Alder H, Nakamura T, Schichman SA, Prasad R, Canaani O, Saito H, Croce CM, Canaani E: Sequence analysis of the breakpoint cluster region in the ALL-1 gene involved in acute leukemia. Cancer Res 54:2327, 1994
25. Chaplin T, Ayton P, Bernard O, Vaskar S, Della Valle V, Hillion J, Gregorini A, Lillington D, Berger R, Young BD: A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukaemia. Blood 85:1435, 1995
26. So CW, Ma ZG, Price CM, Dong S, Chen SJ, Hu LJ, So CKC, Weidemann LM, Chan LC: MLL self fusion mediated by Alu repeat homologous recombination and prognosis of AML-M4/MS subtypes. Cancer Res 57:117, 1997
27. Felix CA, Kim CS, Megonigal MD, Slater DJ, Jones DH, Spinner NB, Stump T, Hosler MR, Nowell PC, Lange BJ, Rappaport EF: Panhandle polymerase chain reaction amplifies MLL genomic translocation breakpoint involving unknown partner gene. Blood 90: 4679, 1997
28. Megonigal M, Rappaport EF, Jones DH, Williams TM, Lovett BD, Kelly KM, Lerou PH, Moulton T, Budarf ML, Felix CA: t(11;22)(q23;q11.2) in acute myeloid leukemia of infant twins fuses MLL with hCDCre1, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocafdiofacial syndromes. Proc Natl Acad Sci USA 95:6413, 1998
29. Megonigal M, Rappaport EF, Jones DH, Kim CS, Nowell PE, Lange BJ, Felix CA: Panhandle PCR strategy to amplify MLL genomic breakpoints in treatment-related leukemias. Proc Natl Acad Sci USA 94:11583, 1997
30. Strissel Broeker PL, Gill Super H, Thirman MJ, Pomykala H, Yonebayshi Y, Tanabe S, Zeleznik-Le N, Rowley JD: Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment related acute myeloid leukemia: Correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood 87:1912, 1996
31. Strout M, Marcucci G, Bloomfield CD, Caligiuri MA: The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia. Proc Natl Acad Sci USA 95:2390, 1998
32. Schichman S, Caligiuri M, Gu Y, Strout M, Carter SL, Gu Y, Canaani E, Bloomfield CD, Croce CM: ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements. Cancer Res 54:4277, 1994
33. Schichman S, Canaani E, Croce CM: Self-fusion of the ALL-1 gene: A new genetic mechanism for acute leukemia. JAMA 273:571, 1995
34. Cimino G, Rapanotti MC, Biondi A, Elia L, Lo Coco F, Price C, Rossi V, Rivolta A, Cananni E, Croce CM, Mandelli F, Greaves M: Infant acute leukemias show the same biased distribution of ALL1 gene breaks as topoisomerase II related secondary acute leukemias. Cancer Res 57:2879, 1997
35. Polijak L, Kas E: Resolving the role of topoisomerase II in chromatin structure and function. Trends Cell Biol 5:348, 1995
36. Warburton PE, Earnshaw WC: Untangling the role of DNA topoisomerase II in mitotic chromosome structure and function. Bioessays 19:97, 1997
37. Adachi Y, Luke M, Laemmli U: Chromosome assembly in vitro: Topoisomerase II is required for condensation. Cell 64:137, 1991
38. Saitoh Y, Laemmli UK: Metaphase chromosome structure: Bands arise from a differential folding path of the highly AT-rich scaffold. Cell 76:609, 1994
39. Sperry A, Blasquez V, Garrard W: Dysfunction of chromosomal loop attachment sites: Illegitimate recombination linked to matrix association regions and topoisomerase II. Proc Natl Acad Sci USA 86:5497, 1989
40. Aplan PD, Chervinsky DS, Stanulla M, Burhans WC: Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. Blood 87:2649, 1996
41. Stanulla M, Wang J, Chervinsky DS, Thandla S, Aplan PD: DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis. Mol Cell Biol Hum Dis Ser 17:4070, 1997
42. Wu C: Two protein-binding sites in chromatin implicated in the activation of heat-shock genes. Nature 309:229, 1984
43. Tuan D, Solomon W, Qiliang L, London IM: The β like globin gene domain in erythroid cells. Proc Natl Acad Sci USA 82:6384, 1985
44. Kaye JS, Bellard M, Dretzen G, Chambon P: A close association between sites of DNase I hypersensitivity and sites of enhanced cleavage by micrococcal nuclease in the 5' flanking region of the actively transcribed ovalbumin gene. EMBO J 3:1137, 1984
45. Langst G, Schatz T, Langowski J, Grummt I: Structural analysis of mouse rDNA: Coincidence between nuclease hypersensitive sites, DNA curvature and regulatory elements in the intergenic spacer. Nucleic Acids Res 25:511, 1997
46. Phi-Van L, Stratling W: The matrix attachment regions of the chicken lysozyme gene co-map with the boundaries of the chromatin domain. EMBO 13:655, 1988
47. Kas E, Laemmli UK: In vivo topoisomerase II cleavage of the Drosophila histone and satellite III repeats: DNA sequence and structural characteristics. EMBO J 11:705, 1992
48. Wu T-C, Lichten M: Meiosis-induced double strand break sites determined by yeast chromatin structure. Science 263:515, 1994
49. Strissel PL, Hart C, Harden A, Rowley JD, Zeleznik-Le N: A DNase I hypersensitive site and an in-vivo topoisomerase II cleavage site both map to the same region near exon 9 of the MLL breakpoint cluster region in various cell lines. Blood 88:65a, 1996 (abstr, suppl 1)
50. Pegoraro L, Matera L, Ritz J, Levis A, Palumbo A, Biagini G: Establishment of a Ph1-positive human cell line (BV173). J Clin Invest 70:447, 1983
51. Allen RJ, Smith SD, Moldwin RL, Min-Min L, Giordano L, Vignon C, Yoshimasa S, Harden A, Tomek R, Veldman T, Reid T, Larson RA, Le Beau MM, Rowley JD, Zeleznik-Le N: Establishment and characterization of a megakaryoblast cell line with amplification of MLL. Leukemia 12:1119, 1998
52. Ohyashiki K, Ohyaskiki JH, Scandberg AA: Cytogenetic characterization of putative human myeloblastic leukemia cell lines (ML-1, -2, and -3): Origin of the cells. Cancer Res 46:3642, 1986
53. MacLeod RAF, Voges M, Drexler HG: Mono Mac 6: A mature monoblastic leukemia cell line with t(9;11)(p21;q23). Blood 82:3221, 1993 (letter)
54. Tanabe S, Zeleznik-Le NJ, Kobayashi H, Vignon C, Espinosa R III, Le Beau MM, Thiman MJ, Rowley JD: Analysis of the t(6;11)(q27; q23) in leukemia shows a consistent breakpoint in AF6 in three patients and in the ML-2 cell line. Genes Chromosomes Cancer 15:206, 1996
55. Pommier Y, Orr A, Kohn KW, Riou JF: Differential effects of amsacrine and epipodophyllotoxins on topoisomerase II cleavage in the human c-myc protooncogene. Cancer Res 52:3125, 1992
56. Mbangkollo D, Burnett RC, Me Cabe NR, Thirman MJ, Gell Super HJ, Yu H, Rowley JD, Diaz MO: The human MLL gene: Nucleotide sequence homology to the Drosophilia trx zinc-finger domain and alternative splicing. DNA Cell Biol 14.475, 1995
57. Me Cabe NR, Burnett RC, Gill HG, Thirman MJ, Mbangkollo D, Kipniak M, van Melle E, Ziemin-van der Poel S, Rowley JD, Diaz MO: Cloning of cDNAs of the MLL gene that detect DNA rearrangments and altered RNA transcripts in human leukemic cells with 11q23 translocations. Proc Natl Acad Sci USA 89:11794, 1992
58. Mirkovitch J, Mirault M, Laemmli U: Organization of the higher-order chromatin loop: Specific DNA attachment sites on nuclear scaffold. Cell 39:223, 1984
59. Maniatis T, Fritsch E, Sambrook J: Molecular Cloning: A Laboratory Manual. New York, NY, Cold Spring Harbor Laboratory, 1982
60. Vaux: Technical tips. Trends Genet 8:81, 1992
61. Rubin C, Carrino J, Dickler M, Leibowitz D, Smith S, Westbrook C: Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia. Proc Natl Acad Sci USA 85:2795, 1988
62. Groffen J, Stephenson J, Heisterkamp N, De Klein A, Bartram C, Grosveld G: Philadelphia chromosomal breakpoints are clustered within a limited region, BCR, on chromosome 22. Cell 36:93, 1984
63. Schaefer-Rego K, Leibowitz D, Mears J: Chromatin alterations surrounding the BCR/ABL fusion gene in K562 cells. Oncogene 5:1669, 1990
64. Nucifora G, Rowley ID: AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 86:1, 1995
65. Ueda K: Multidrug resistance of cancer cells mediated by ABC superfamily transporters. Nippon Rinsho 55:1024, 1997
66. Singh SP, Mohamed R, Salmond C, Lavin MF: Reduced DNA topoisomerase II activity in ataxia-telangiectasia cells. Nucleic Acids Res 16:3919, 1988
67. Hong JH, Kusunoki Y, Komazawa Y, Mizutani A, Mizuno T, Kuramoto A, Kamada N: Isolation and characterization of VP-16 resistant human leukemia cell line. Biomed Pharmacother 44:35, 1990
68. Stanulla M, Wang J, Chervinsky DS, Aplan PD: Topoisomerase II inhibitors induce DNA souble strand breaks at a fragile site within the AML1 locus. Leukemia 11:490, 1997
69. Chen S, Grausz D, Hillion J, D'Auriol L, Flandrin G, Larsen C, Berger R: Molecular cloning of a 5' segment of the genomic ph1 gene defines a new breakpoint cluster region (bcr2) in Philadelphia-positive acute leukemias. Leukemia 2:634, 1988
70. Greaves MF: Workshop report. Infant leukemia biology, aetiology and treatment. Leukemia (Baltimore) 10:372, 1996
71. Ross JA, Davies SM, Potter JD, Robinson LL: Epidemiology of childhood leukemia with a focus on infants. Epidemiol Rev 16:243, 1994
72. Kingma PS, Greider CA, Osheroff N: Spontaneous DNA lesions poison human topoisomerase II α and stimulate cleavage proximal to leukemic 11q23 chromosomal breakpoints. Biochemistry 36:5934, 1997
73. Pastorcic M, Bagchi MK, Tsai SY, O'Malley BO: Multiple protein binding sites within the ovalbumin gene 5' flanking region: isolation and characterization of sequence specific binding proteins. Nucleic Acids Res 17:6693, 1989
74. Fleenor D, Kaufman RE: Characterization of the DNase I hypersensitive site 3' of the human β globin gene domain. Blood 8:2781, 1993
75. Strick R, Laemmli UK: SARs are cis DNA elements of chromosome dynamics: Synthesis of a SAR repressor protein. Cell 83:1137, 1995